Debt Management: Stryker's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.76, the ...

Ahead of BTS’ mega-tour blowout – and with their company’s stock price up more than 50% from mid-January 2025 – Hybe execs ...

As of Tuesday morning, Corcept Therapeutics shares are down by 0.59%, with a current price of $79.35. This implies that Belanoff's 550,000 shares have a value of $41,508,500.

The founder of a mental health startup who's facing felony charges following an erratic episode at a Saratoga winery was ...

Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.

Daniel Nathan and Brian Neil Hoffman of Morrison & Foerster write: Stock option exercises may create additional risks of violating the securities laws depending upon how they are exercised. Through ...

Highlighted on May 7, it was unveiled in an SEC filing that Sutton, Director at Ameresco (NYSE:AMRC), executed a significant transaction involving the exercise of company stock options. What Happened: ...

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (CUSN:CA) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its ...